Barrington Research Maintains Outperform Rating on IMAX (IMAX)

Article Related Press Releases (1) Related Articles (2) Stock Quotes (1) Comments (0)

Barrington Research today reiterated a Buy rating on IMAX Corporation (NYSE: IMAX) and trimmed its price target to $36 from $37. Last week IMAX Corp. reported Q4 EPS of $0.23, $0.07 better than the analyst estimate of $0.16. Revenue for the quarter came in at $77.8 million versus the consensus estimate of $74 million.

Commenting on the news, analyst James C. Goss said, "Our $36 target price is aggressive, but is based on a 20x EV/EBITDA multiple reflecting our expectation that roughly 20% annual gains in screen count will be further supplemented by margin upside for the reasons we have outlined. A shift in the shareholder base to longer-term investors focused on the business model development rather than film by film successes should be attractive to an increasing number of investors."

For an analyst ratings summary and ratings history on IMAX Corporation (NYSE: IMAX) click here. For more ratings news on IMAX Corporation click here.

Shares of IMAX Corporation closed at $26.02 yesterday, with a 52 week range of $18.29-$26.73.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
• Terex (TEX) Suffers from Weakness in Europe; Read-Through For Manitowoc (MTW)
• Deutsche Bank Sees Upside in AIG (AIG) Stock

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?